Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.9K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.4K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.4K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.3K
2.3K
Adult Stem Cells01:33

Adult Stem Cells

34.3K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
34.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transposable elements shape stemness in normal and leukemic hematopoiesis.

Nature genetics·2026
Same author

A stem and progenitor cell-derived gene expression signature is prognostic for survival in myelofibrosis.

Blood·2026
Same author

A Rapid Gene Expression Profiler Classifies AML Tumor Responsiveness to Standard Therapies.

bioRxiv : the preprint server for biology·2025
Same author

Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia.

Haematologica·2025
Same author

Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacy.

Frontiers in immunology·2025
Same author

FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human hematopoietic stem cells.

Blood·2025

Related Experiment Video

Updated: Mar 30, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.9K

Bringing Leukemia Stem Cells into the Clinic.

Jean C Y Wang1

  • 1Princess Margaret Cancer Research Centre, University Health Network, Toronto, Ont., Canada.

Oncology
|November 10, 2015
PubMed
Summary
This summary is machine-generated.

New therapies are needed for acute myeloid leukemia (AML) to target leukemia stem cells (LSC) and preleukemic stem cells (preL-HSC) driving relapse. Xenotransplantation models show clinical validity for studying AML stem cell biology and developing targeted treatments.

More Related Videos

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

2.0K
Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

4.7K

Related Experiment Videos

Last Updated: Mar 30, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.9K
Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

2.0K
Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

4.7K

Area of Science:

  • Hematology
  • Cancer Biology
  • Stem Cell Research

Background:

  • Outcomes for acute myeloid leukemia (AML) patients are poor, with high relapse rates.
  • Relapsed disease is driven by leukemia stem cells (LSC) and preleukemic hematopoietic stem cells (preL-HSC).
  • There is a critical need for novel therapies targeting these specific stem cell populations.

Purpose of the Study:

  • To validate the use of xenotransplantation models for studying AML stem cell biology.
  • To propose a new framework for developing LSC-targeted therapies.
  • To identify biomarker tools for patient selection in AML treatment.

Main Methods:

  • Utilizing xenotransplantation models with immunodeficient mice.
  • Functional assays to assess stem cell properties.
  • Investigating the biological mechanisms of LSC and preL-HSC.

Main Results:

  • Demonstrated clinical validity of xenotransplantation models for AML stem cell research.
  • Provided evidence supporting the role of LSC and preL-HSC in disease relapse.
  • Established a foundation for developing novel therapeutic strategies.

Conclusions:

  • Xenotransplantation models are crucial for understanding AML stem cell biology.
  • Targeting LSC and preL-HSC offers a promising therapeutic avenue.
  • Development of LSC-targeted agents and biomarkers is essential for improving AML patient outcomes.